Tim is a tech entrepreneur from the Cambridge Cluster, passionate about using big data and AI to accelerate treatments for rare diseases. He is Co-Founder and Chief Executive of Healx, the AI powered, patient-inspired tech company, accelerating the discovery and development of rare disease treatments at scale. As CEO of Healx, Tim has been listed in The Sunday Times Maserati 100 list in 2019, was named as "one to watch" in The Telegraph’s Top 50 Most Ambitious Business Leaders in 2020 and was selected as a member of the Forbes Technology Council in 2022. Tim is also the Co-Founder and Trustee of the Cambridge Rare Disease Network (CRDN). Prior to Healx and CRDN, he obtained his PhD at the University of Cambridge in the field of Biophysics and Neuroscience, developing nanobody technology for Parkinsons disease.
AI and Data Sciences Showcase:
Healx combines frontier AI technology with deep drug discovery and development expertise to accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development.
Pioneering the Next Generation of Drug Discovery for Rare Disease
Hear how Healx are developing a new approach to drug discovery for rare diseases.
The PMWC 2023 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.